Overview

Trial of Simvastatin and Gemcitabine in Pancreatic Cancer Patients

Status:
Completed
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether simvastatin is effective in the treatment of advanced pancreatic cancer patients.
Phase:
Phase 2
Details
Lead Sponsor:
Samsung Medical Center
Treatments:
Gemcitabine
Simvastatin